ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 109825 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 109825; 2) Community: the network communities that were significantly associated with the response to NSC 109825; 3) Molecule: the relationships between components within communities and NSC 109825; 4) MDR: the compounds that were significantly associated with the NSC 109825.

NSC Compound Enrichment Correlation
NSC 330507 Tanespimycin 0.0286383688883668 0.10081371
NSC 346098 Null 0.0286383688883668 -0.077091485
NSC 408171 Null 0.0286383688883668 0.033652284
NSC 58573 Pyrimidine, 2,4,5-trichloro-6-ethyl- 0.0286383688883668 -0.14000723
NSC 642009 Butanedioic acid, 2-[[2-[(3-chloro-1,4-dihydro-1,4-dioxo- 2-naphthalenyl)amino]1,2-dioxo]ethyl]-3-oxo-, dimethyl ester 0.0286383688883668 0.35816483
NSC 645810 Null 0.0286383688883668 0.11514727
NSC 665087 Null 0.0286383688883668 0.1322761
NSC 671095 Null 0.0286383688883668 0.38489501
NSC 682769 5H-Pyrido[3,2-d][2]benzazepin-6(7H)-one, 4-(3,4-dimethoxyphenyl)-2-phenyl- 0.0286383688883668 0.16662903
NSC 692576 3-Pyridinecarboxylic acid, 2-[[(2-chloro-3-pyridinyl)amino]carbonyl]-1,4-dihydro- 4-(2,4-dimethoxyphenyl)-1-(4-methoxy-2-nitrophenyl)- 6-(4-methylphenyl)-, methyl ester 0.0286383688883668 -0.0033929048
Total:59  Current:32    [First] [Prev] [Next] [Last]